POWERbreathe International Ltd

POWERbreathe International Ltd is a world leader in evidence-based respiratory muscle training devices and technology. The company develops drug-free, clinically validated breathing training and testing systems used across medical and sports applications. POWERbreathe's Inspiratory Muscle Training (IMT) devices use resistance-based principles to strengthen respiratory muscles and are supported by over 200 independent medical and sports research studies. The company's newer Expiratory Muscle Training (EX1) series, launched in 2023, enables more forceful and powerful exhalation. Products are NHS-approved and have demonstrated clinical benefits including reduced blood pressure, improved breathing strength and stamina, enhanced exercise tolerance, and alleviation of breathlessness in patients with respiratory conditions. The ActiBreathe® mobile app with Smart Adaptor provides digital monitoring, personalized training protocols, and performance tracking. Applications span medical conditions (asthma, COPD, post-COVID recovery, neuromuscular disease), sports performance enhancement, fitness, and general respiratory health.